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ABSTRACT
Objective: It has been hypothesised that clinically important age-related differences between adults with
anxiety disorders exist; this study aims to elucidate these differences.
Methods: We analysed data from 1950 outpatients diagnosed with DSM-IV-TR anxiety disorders treated at
a Dutch hospital or affiliated mental healthcare centres. Three age-groups (young- (18–25; n¼ 435), mid-
(26–40; n¼ 788) and older adult (41–65; n¼ 727)) were compared with regard to social demographic char-
acteristics, diagnostic characteristics, anxiety symptom profile, general psychiatric symptom profile and
generic health status, in addition, linear analyses were carried out with age as a continuous variable.
Results: Average age was 36.48 years (SD 11.71), 62.8% were female. Significant associations with age
emerged for gender, employment, education level, living situation, observed depression, agoraphobia
(AP), social phobia, aches and pains, inner tension, sleep, interpersonal sensitivity, observed hostility, phys-
ical functioning, role limitations due to physical problems, vitality and bodily pain in categorical and con-
tinuous analyses. Self reported hostility was only significant in group-wise comparisons; role limitations
due to emotional problems were only significant in linear analyses (all at p< .001).
Conclusions: This study identified clinically relevant differences between younger and older adult outpa-
tients with anxiety disorders. Clinicians should take these findings into account, as they may support
treatment.
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Adult psychiatry is generally regarded as a uniform concept, with
homogenous treatment protocols and guidelines. However,
between an 18-year old and a 60-year old diagnosed with an anx-
iety disorder, numerous differences may exist. Age related differ-
ences in the adult population might, for example, be related to
changes in physical health associated with aging. In addition,
social demographic cohort differences impacting emotionality,
such as lower education levels and related competitive disadvan-
tages in the labour market among older subjects, could exist
(Schieman et al. 2001). Finally, possibly relevant differences
between life phases exist: During ages 18–25, achieving social,
psychological and financial independence are central. Ages 26
through 40, are marked by growing responsibilities associated
with career development and family planning. During ages 41
through 65, interests shift to social responsibility, caregiving
duties, helping the next generation and adjusting to approaching
retirement and post-work identity (Wong et al. 2015). Altogether,
these physical changes, cohort differences and life phases may
impact the phenomenology of anxiety disorders, which in turn
may require different diagnostic and therapeutic approaches from
health care professionals (Schneider et al. 2004; Husain et al.
2005).
To date, however, the phenomenology of anxiety across the
adult life span has not been studied extensively. Therefore, this
study explored age-related differences in anxiety disorders. We
focused on outpatients diagnosed with (DSM-IV-TR) (American
Psychiatric Association 2000) panic disorder (with or without
agoraphobia) (PD), agoraphobia (without panic) (AP), social pho-
bia (SP) and generalised anxiety disorder (GAD). We compared
data on a broad set of social demographic, clinical and func-
tional characteristics. With regard to social demographic charac-
teristics, on average, we expected older patients to have lower
education levels, to more often live with a partner and to be
employed less often. Based on previous findings in depression
(Husain et al. 2005; Wilkowska-Chmielewska et al. 2013), and on
comparisons between adult subjects with anxiety disorders with
child- and adolescent and geriatric subjects, respectively
(Wolitzky-Taylor et al. 2010; Lenze & Wetherell 2011), several
hypotheses with regard to clinical characteristics could be for-
mulated: we hypothesised more panic in younger patients
(Wolitzky-Taylor et al. 2010) and more drug abuse in younger
subjects (Husain et al. 2005). With regard to symptom presenta-
tion we expected more irritability in younger patients (Husain
et al. 2005; Lenze & Wetherell 2011; Wilkowska-Chmielewska
et al. 2013), more anhedonia in younger patients (Wilkowska-
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Chmielewska et al. 2013), and more health-related worry in older
patients (Husain et al. 2005; Wolitzky-Taylor et al. 2010; Lenze &
Wetherell 2011). In addition, we expected older patients to have
more physical complaints, more sleep problems, less vitality and
more pain (Husain et al. 2005; Lenze & Wetherell 2011). In order
to fully explore associations with age, we examined age-related
differences allowing for non-linear associations, as well as linear
associations. This study is the first to examine age related differ-
ences among adults with anxiety disorders. Findings may help




As part of routine practice at the facilities involved in this study,
all patients completed an extensive battery of self-report and
observer-rated measures at intake. This procedure is known as
routine outcome monitoring (ROM), and is described in more
detail by De Beurs et al. (2011). Both generic and disorder-specific
questionnaires were administered by trained psychiatric nurses
and through supervised computerised self-report which prevented
missing data within questionnaires. Although participation in ROM
is voluntary, inclusion is high with an estimated 80% of all
patients being assessed at intake (van Noorden et al. 2011;
Zitman 2012). Although the primary goal of ROM is to inform
both clinicians and patients, data were anonymised and their use
in scientific research was approved by the Ethical Review Board at
the Leiden University Medical Centre (LUMC).
Patients and procedure
Subjects were outpatients who had been referred for treatment
by their general practitioner to Rivierduinen, a regional mental
healthcare provider, or the psychiatry department of the LUMC
between January 2004 and October 2010. Inclusion criteria held
that patients must be between ages 18 and 65, have adequate
command of the Dutch language and meet DSM-IV-TR diagnostic
criteria for one or more of the following disorders: PD, AP, SP or
GAD; with moderate to severe anxiety. Moderate to severe anxiety
severity was assessed using a self-report as well as an observa-
tional measure: the Dutch versions of the Brief Symptom
Inventory-12 item version (BSI-12) (Roy-Byrne et al. 2010), a self-
report anxiety measure derived from the BSI (Derogatis &
Melisaratos 1983; De Beurs & Zitman 2006) and the observer-rated
Brief Anxiety Scale (BAS) (Tyrer et al. 1984) (see ‘Measures’ sec-
tion). Moderate to severe baseline severity was defined as 10.38
on the BAS (Tyrer et al. 1984; Schat et al. 2013), equalling the
average BAS score in a group of general practice patients diag-
nosed with anxiety disorders (Tyrer et al. 1984), and 6 on the
BSI-12 (Schat et al. 2013), with scores<6 signifying no- to mild
anxiety (Roy-Byrne et al. 2010). Missing data resulting from the
incidental failure to administer complete questionnaires and from
large time intervals between administrations of questionnaires
served as exclusion criteria.
Measures
In addition to patients’ age and gender, education level (low: pri-
mary-lower secondary versus high: higher secondary-university),
living situation (with versus without partner), and employment
status (full- or part-time employed versus unemployed) were
assessed. The Dutch version of the MINI International
Neuropsychiatric Interview-Plus (MINI-Plus) (Sheehan et al. 1998;
Van Vliet & De Beurs 2007) was used to collect diagnostic
information. The MINI-Plus has good psychometric properties
(Lecrubier et al. 1997), and was used to determine the presence
of DSM-IV-TR anxiety disorders, comorbid depressive or dysthymic
disorders, alcohol abuse or -dependence and drug abuse or
-dependence. The number of comorbid anxiety disorders (includ-
ing comorbid specific phobia) was dichotomised into ‘single anx-
iety disorder’ versus ‘multiple anxiety disorders.’ Anxiety
symptoms were assessed using the BAS (Tyrer et al. 1984). The
BAS is a 10-item observer-rated scale, derived from the abbrevi-
ated Comprehensive Psychopathological Rating Scale (CPRS)
(Asberg et al. 1978; Goekoop et al. 1992). The total score equals
the sum-score of all 10 items on a 7-point Likert scale (0–6) (range
0–60). The BAS assesses the main components of all anxiety disor-
ders, covering psychological and somatic components, a higher
score corresponds to more severe anxiety. The 25-item CPRS,
besides measuring anxiety on the BAS, also measures depressive
symptoms (Montgomery–Åsberg Depression Rating Scale, MADRS)
with 10 items. Items are measured on a 7-point Likert scale (0–6)
and add up to a total score (range 0–60), with higher scores
indicating more severe symptoms. The MADRS has good internal
consistency with Cronbach’s alpha equalling 0.86 (Montgomery &
Asberg 1979). The BSI (Derogatis & Melisaratos 1983; De Beurs &
Zitman 2006) was used to assess a general psychiatric symptom
profile. The BSI is a self-report measure consisting of 53 items
on a 5-point Likert scale (0–4) (range 0–48). A total of nine sub-
scales (somatisation, obsessive compulsive symptoms, interper-
sonal sensitivity, depression, anxiety, hostility, phobic anxiety,
paranoid ideation and psychoticism) can be obtained by averag-
ing the corresponding items. Generic health status was examined
using the Dutch version of the Short Form-36 (SF-36) (Ware &
Sherbourne 1992; Aaronson et al. 1998), a 36-item self-report
survey screening eight domains of general health: physical func-
tioning, social functioning, role limitations due to physical health
problems, role limitations due to emotional problems, general
mental health perception, vitality, bodily pain, and general health
perception. Measurement scales vary per subscale, ranging from
yes/no to answers on a 3-, 5- or 6-point Likert scale. All raw
scores are linearly converted to 0–100 subscales, with higher
scores representing higher levels of functioning or wellbeing.
However, to facilitate comparability to other measures, SF-36
scores were inverted so that higher scores reflect poorer generic
health.
Statistical analyses
Categorical characteristics are presented as number (percentage),
continuous variables are presented as mean (M) (±SD).
Comparisons between included and excluded patients were made
using v2 for categorical and independent samples t-tests for con-
tinuous variables. Based on previous studies, patients were divided
into three cohorts: age 18–25; 26–40 and 41–65 (Robins et al.
1984; Regier et al. 1990; Somers et al. 2006; van Noorden et al.
2011). Age-groups were compared with regard to demographic
variables, diagnostic variables, anxiety symptom profile (BAS), gen-
eral psychiatric symptom profile (BSI) and generic health status
(SF-36). Comparisons between the three age-groups were made
using v2 or ANOVA for categorical and continuous variables
respectively, with pair-wise post-hoc comparisons. For overall
comparisons Cramer’s V or Eta squared were calculated, for pair-
wise post-hoc comparisons, phi and Cohen’s d were computed.
To test whether associations fitted a linear shape, in addition, all
variables were examined in linear regression. Significance level
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was set at p< .05; Bonferroni correction for multiple testing was




Between January 2004 and October 2010, a total of 2214 patients
met DSM-IV-TR diagnostic criteria for PD, AP, SP and GAD with at
least moderate severity. 264 patients (11.9%) had to be excluded,
as they had missing data, or a large time gap (more than 21 d)
existed between completion of distinct questionnaires. The latter
criterion was set to guarantee that all assessments had taken
place at intake. Therefore, 1950 patients (88.1%) were included for
analyses. Although differences between included and excluded
patients with regard to BAS item ‘aches and pains,’ BSI subscales
‘cognitive distortion,’ ‘hostility,’ and ‘phobic anxiety’ and SF-36
subscale ‘bodily pain’ were significant at p< .05 after Bonferroni
correction, these differences were very small, with eta squared
ranging from 0.001 to 0.01 (results not shown). Of the total sam-
ple, 62.8% was female, mean age was 36.48. A total of 816
patients (42%) was diagnosed with PD, 433 (22%) patients with
AP, 586 patients (30%) with SP, and 440 patients (23%) with GAD.
Patients were divided according to age in early adult (age 18–25;
n¼ 435), mid-adult (age 26–40; n¼ 788) and late adult (age
41–65; n¼ 727).
Differences between age-groups
Social demographic and clinical characteristics
Social demographic and clinical comparisons across the three age-
groups with pairwise post-hoc analyses with Bonferroni correction
as well as results for regression analyses are summarised in
Table 1. Significant associations with age emerged for gender,
employment, education level, living situation and comorbid
depression. The percentage of men increased with age (28.0% in
the early adult group, 36.5% in the mid-adult and 43.3% in the
late adult group). The percentage of patients with a part-time or
fulltime job decreased with age (46.6% in the early adult group,
47.0% in the mid-adult group and 37.7% in the late adult group),
as did the number of patients with a high education level (65.5%
in the early adult group, 60.8% in the mid-adult group and 47.9%
in the late adult group). Older patients were more likely to live
with a partner than younger patients (22.3% in the early adult
group, 58.1% in the mid-adult group and 64.4% in the late adult
group). Younger patients were less likely to have a comorbid
depressive disorder (48.5% in the early adult group, 51.6% in the
mid-adult group and 60.8% in the late adult group). The distribu-
tion of the four included DSM-IV-TR anxiety diagnoses (PD, AP, SP
and GAD) across the three age-groups is shown in Figure 1. AP
was more prevalent with increasing age (17.2%) in the early adult
group, 18.8% in the mid-adult group and 28.9% in the late adult
group). The number of patients with SP on the other hand
decreased with age (39.8% in the early adult group, 30.7% in the
mid-adult group and 23.5% in the late adult group).
Anxiety symptoms
Comparisons of anxiety symptoms across the three age-groups
with pairwise post-hoc analyses with Bonferroni correction, as
well as results for regression analyses are shown in Table 2.
Significant differences between the three age-groups emerged
on the items aches and pains, inner tension and reduced sleep.
Complaints of aches and pains increased with age (early adult
group M¼ 1.93, SD¼ 1.37; mid-adult group M¼ 2.09, SD¼ 1.45;
late adult group M¼ 2.29, SD¼ 1.52), as did levels of inner ten-
sion (early adult group M¼ 3.03, SD¼ 1.00; mid-adult group
M¼ 3.15, SD¼ 1.01; late adult group M¼ 3.29, SD¼ 1.00) and
sleep problems (early adult group M¼ 1.81, SD¼ 1.59; mid-adult
group M¼ 2.22, SD¼ 1.68; late adult group M¼ 2.43, SD¼ 1.74).
Although group-wise comparisons were not statistically signifi-
cant, regression analyses showed a decrease in hostility scores
with age.
Psychiatric symptoms
Table 3 shows comparisons of psychiatric symptoms across the
three age-groups with pairwise post-hoc analyses with Bonferroni
correction, as well as results for regression analyses. With regard
to psychiatric symptoms, significant differences between the three
age-groups emerged on measures of interpersonal sensitivity, hos-
tility and on observed depression. Levels of interpersonal
Table 1. Social demographic and clinical patient characteristics per age-group in 1950 outpatients diagnosed with DSM-IV-TR anxiety disorders.
Categorical comparison
Early adult (E) Mid adult (M) Late adult (L)
Overall phi post-hoc Linear comparison
18–25 (n¼ 435) 26–40 (n¼ 788) 41–65 (n¼ 727) Cramer’s V p EM E L M L B (95% CI) p
Male gender n (%) 122 (28.0) 288 (36.5) 315 (43.3) 0.12 <.001 0.09 0.12 0.07 2.83 (1.76–3.89) <.001
Fulltime or part time job n (%) 203 (46.7) 370 (47.0) 274 (37.7) 0.09 <.001 – 0.13 0.09 2.45 (3.49–1.40) <.001
High education level n (%) 285 (65.5) 479 (60.8) 348 (47.9) 0.15 <.001 – 0.18 0.13 4.03 (5.06–2.99) <.001
Living with partner n (%) 97 (22.3) 458 (58.1) 468 (64.4) 0.33 <.001 0.34 0.45 0.06 6.60 (5.60–7.59) <.001
Comorbid depression n (%) 211 (48.5) 407 (51.6) 442 (60.8) 0.10 <.001 – 0.22 0.09 2.52 (1.48–3.56) <.001
Substance abuse/dep. n (%) 28 (6.4) 39 (4.9) 25 (3.4) – .06 – – – 2.88 (5.33–0.43) .02
Alcohol abuse/dep. n (%) 23 (5.3) 43 (5.5) 54 (7.4) – .20 – – – 2.40 (0.24–4.56) .03
Multiple anxiety disorders n (%) 80 (18.4) 122 (15.5) 102 (14.0) – .14 – – – 1.12 (0.31–2.56) .12
Panic disorder 178 (40.9) 352 (44.7) 286 (39.3) – .10 – – – 0.30 (0.10–0.04) .39
Agoraphobia 75 (17.2) 148 (18.8) 210 (28.9) – <.001 – 0.12 0.12 0.21 (0.13–0.29) <.001
Social phobia 173 (39.8) 242 (30.7) 171 (23.5) – <.001 0.09 0.23 0.08 0.22 (0.29–0.15) <.001
Generalised anxiety disorder 92 (21.1) 177 (22.5) 171 (23.5) – .64 – – – 0.04 (0.04–0.12) .35
Social demographic and clinical categorical patient characteristics per age-group in 1950 outpatients diagnosed with DSM-IV-TR anxiety disorders (panic disorder
with or without agoraphobia, agoraphobia without panic, social phobia and/or generalised anxiety disorder). Comparisons between the three age-groups were made
using Chi-squared test with post-hoc comparisons using Bonferroni correction for multiple testing. The MINI International Neuropsychiatric Interview-Plus (MINI-Plus)
was used to collect DSM-IV-TR diagnostic information (type of anxiety disorder, number of simultaneously occurring anxiety disorders, presence of a comorbid mood
disorder, comorbid alcohol- or substance abuse or -dependence); DSM-IV-TR denotes Diagnostic Statistical Manual-fourth edition, text revision; E denotes the early
adult group (18–25; n¼ 435); M denotes the mid-adult group (26–40; n¼ 788); L denotes the late adult group (41–65; n¼ 727).
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sensitivity decreased with age (early adult group M¼ 2.06,
SD¼ 1.08; mid-adult group M¼ 1.94, SD¼ 0.94; late adult group
M¼ 1.73, SD¼ 1.06), as did levels of self-reported hostility (early
adult group M¼ 1.18, SD¼ 8.30; mid-adult group M¼ 1.12,
SD¼ 0.92; late adult group M¼ 0.95, SD¼ 0.85). Observed depres-
sion scores on the other hand, increased with age (early adult
group M¼ 18.69, SD¼ 8.30; mid-adult group M¼ 20.38, SD¼ 8.31;
late adult group M¼ 21.82, SD¼ 8.54).
Figure 1. Anxiety diagnoses per age-group in 1950 outpatients diagnosed with DSM-IV-TR anxiety disorders. Anxiety diagnoses per age-group in 1950 outpatients
diagnosed with DSM-IV-TR anxiety disorders (panic disorder with or without agoraphobia, agoraphobia without panic, social phobia and/or generalised anxiety dis-
order); DSM-IV-TR denotes Diagnostic Statistical Manual-fourth edition, text revision; denotes significantly different from early adult (18–25; n¼ 435) and mid-adult
(26–40; n¼ 788) post-hoc with Bonferroni correction for multiple testing; denotes significantly different from early adult (18–25; n¼ 435) and late adult (41–65;
n¼ 727) post-hoc with Bonferroni correction for multiple testing.
Table 2. Anxiety symptoms per age-group in 1950 outpatients diagnosed with DSM-IV-TR anxiety disorders.
Categorical comparison
Early adult (E) Mid adult (M) Late adult (L)
Overall Cohen’s d post-hoc Linear comparison
18–25 (n¼ 435) 26–40 (n¼ 788) 41–65 (n¼ 727) Eta squared p EM E L M L B (95% CI) p
Aches and pains 1.93 (1.37) 2.09 (1.45) 2.29 (1.52) 0.01 <.001 – 0.25 – 0.85 (0.50–1.20) <.001
Inner tension 3.03 (1.00) 3.15 (1.01) 3.29 (1.00) 0.01 <.001 – 0.26 – 1.24 (0.72–1.75) <.001
Hypochondria 0.51 (0.97) 0.63 (1.12) 0.62 (1.08) – .14 – – – 0.13 (0.36–0.61) .60
Worries 1.90 (1.60) 2.02 (1.63) 1.82 (1.64) – .07 – – – 0.15 (0.47–0.17) .36
Phobia 2.25 (1.82) 2.12 (1.84) 2.16 (1.87) – .52 – – – 0.15 (0.43–0.13) .30
Hostility 1.63 (1.39) 1.73 (1.38) 1.49 (1.40) – .003 – – – –0.71 (1.08–0.34 <.001
Reduced sleep 1.81 (1.59) 2.22 (1.68) 2.43 (1.74) 0.02 <.001 0.25 0.37 – 0.94 (0.63–1.24) <.001
Reported autonomic dist. 2.49 (1.10) 2.56 (1.18) 2.67 (1.16) – .02 – – – 0.50 (0.05–0.95) .03
Apparent autonomic dist. 1.15 (1.09) 1.01 (1.07) 1.04 (1.08) – .09 – – – –0.39 (0.97–0.10) .12
Apparent muscle tension 1.69 (1.11) 1.68 (1.15) 1.70 (1.18) – .90 – – – 0.04 (0.42–0.49) .88
Anxiety symptoms as measured with the Brief Anxiety Scale (BAS) per age-group in 1950 outpatients diagnosed with DSM-IV-TR anxiety disorders (panic disorder
with or without agoraphobia, agoraphobia without panic, social phobia and/or generalised anxiety disorder). Comparisons between the three age-groups were made
using Chi-squared test with post-hoc comparisons using Bonferroni correction for multiple testing. Anxiety symptoms were measured with the Brief Anxiety Scale.
DSM-IV-TR denotes Diagnostic Statistical Manual-fourth edition, text revision; E denotes the early adult group (18–25; n¼ 435); M denotes the mid-adult group
(26–40; n¼ 788); L denotes the late adult group (41–65; n¼ 727); Reported autonomic dist. denotes the subscale reported autonomic disturbances; Apparent auto-
nomic dist. denotes the subscale apparent autonomic disturbances.
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Generic health status
Comparisons across the three age-groups with regard to generic
health status with pairwise post-hoc analyses with Bonferroni cor-
rection, as well as results for regression analyses are summarised in
Table 4. Significant differences emerged between the three age-
groups with regard to physical functioning, role limitations due to
physical problems, role limitations due to emotional problems, vital-
ity and bodily pain. Physical functioning deteriorated with age (early
adult group M¼ 20.05, SD¼ 20.42; mid-adult group M¼ 23.93,
SD¼ 22.05; late adult group M¼ 30.77, SD¼ 24.40). Physical prob-
lems increased with age (early adult group M¼ 56.78, SD¼ 39.36;
mid-adult group M¼ 64.78, SD¼ 38.48; late adult group M¼ 71.70,
SD¼ 36.83), as did the level of role limitations due to emotional
problems (early adult group M¼ 70.88, SD¼ 34.54; mid-adult group
M¼ 80.16, SD¼ 30.43; late adult group M¼ 78.4, SD¼ 32.07). Levels
of vitality decreased with age (early adult group M¼ 64.54,
SD¼ 15.45; mid-adult group M¼ 67.26, SD¼ 15.93; late adult group
M¼ 68.65, SD¼ 16.43), while the level of bodily pain increased with
age (early adult group M¼ 32.77, SD¼ 24.38; mid-adult group
M¼ 36.71, SD¼ 27.15; late adult group M¼ 39.95, SD¼ 28.22).
Discussion
We identified a number of differences between the three age-
groups of outpatients with anxiety disorders. A number of
findings fit our hypotheses. The findings that older patients more
often lived with a partner, were less often employed, and had
lower education levels fit general demographics (Lutz & KC 2011).
The finding of more physical symptoms in older patients is also
in line with the process of aging (Aaronson et al. 1998),
although it is of note that signs of significantly lower physical
functioning were already observed in the mid-adult group rela-
tive to the early adult group. Possibly our results reflect the
overall finding that people with anxiety disorders are at elevated
risk for a number of physical conditions (Sareen et al. 2005) and
that this risk increases with age (Brenes et al. 2008; Scott et al.
2008).
The shift in the male to female ratio towards a more equal dis-
tribution with increasing age was previously reported in the gen-
eral population (Regier et al. 1990). With regard to anxiety
diagnoses, we found a decrease in SP with age, which has also
been found in the general population (Somers et al. 2006). AP on
the other hand was more prevalent in the late adult group. This
again confirms findings in the general population (Cairney et al.
2008), although prevalence of AP has also been found to be sta-
ble or even decline across age-groups (Somers et al. 2006).
However, across all age-groups, mood-disorder comorbidity was
common, but it was highest in the oldest group. This was not
reflected in self-reported depression scores. Possibly, the increased
prevalence of physical complaints with age may have inflated
chances of meeting diagnostic criteria for depression. As such, the
Table 3. Psychiatric symptoms per age-group in 1950 outpatients diagnosed with DSM-IV-TR anxiety disorders.
Categorical comparison
Early adult (E) Mid adult (M) Late adult (L)
Overall Cohen’s d post-hoc Linear comparison
18–25 (n¼ 435) 26–40 (n¼ 788) 41–65 (n¼ 727) Eta squared p EM E L M L B (95% CI) p
MADRS 18.69 (8.30) 20.38 (8.31) 21.82 (8.54) 0.01 <.001 0.20 0.37 0.17 0.19 (0.13–0.25) <.001
BSI Depression 1.86 (0.98) 1.84 (0.97) 1.84 (0.98) – .92 – – – 0.11 (0.65–0.42) .69
BSI Somatisation 1.30 (0.80) 1.37 (0.87) 1.35 (0.89) – .44 – – – 0.15 (0.45–0.75) .63
BSI Obsessive compulsive 1.77 (0.92) 1.91 (0.94) 1.89 (0.95) – .03 – – – 0.31 (0.24–0.86) .27
BSI Interpersonal sensitivity 2.06 (1.08) 1.94 (1.07) 1.73 (1.06) 0.01 <.001 – 0.38 0.20 1.35 (1.83–0.87) <.001
BSI Anxiety 2.01 (0.86) 2.07 (0.87) 2.05 (0.87) – .53 – – – 0.14 (0.46–0.74) .65
BSI Hostility 1.18 (0.93) 1.12 (0.92) 0.95 (0.85) 0.01 <.001 – 0.26 0.19 1.62 (2.19–1.04) <.001
BSI Phobic anxiety 1.76 (0.99) 1.72 (0.96) 1.65 (0.99) – .11 – – – 0.67 (1.20–0.13) .01
BSI Paranoid ideation 1.34 (0.97) 1.37 (1.00) 1.29 (0.98) – .24 – – – 0.44 (0.97–0.09) .10
BSI Psychoticism 1.47 (0.81) 1.50 (0.84) 1.38 (0.83) – .02 – – – 0.85 (1.47–0.22) .008
Psychiatric symptoms as measured with the Montgomery Åsberg Depression Rating Scale (MADRS) and the Brief Symptom Inventory (BSI) per age-group in 1950
outpatients diagnosed with DSM-IV-TR anxiety disorders (panic disorder with or without agoraphobia, agoraphobia without panic, social phobia and/or generalised
anxiety disorder). Comparisons between the three age-groups were made using ANOVA with post-hoc comparisons using Bonferroni correction for multiple testing.
BSI denotes Brief Symptom Inventory; DSM-IV-TR denotes Diagnostic Statistical Manual-fourth edition, text revision; E denotes the early adult group (18–25;
n¼ 435); M denotes the mid-adult group (26–40; n¼ 788); L denotes the late adult group (41–65; n¼ 727).
Table 4. Generic health status per age-group in 1950 outpatients diagnosed with DSM-IV-TR anxiety disorders.
Categorical comparison
Early adult (E) Mid adult (M) Late adult (L)
Overall Cohen’s d post-hoc Linear comparison
18–25 (n¼ 435) 26–40 (n¼ 788) 41–65 (n¼ 727) Eta squared p E – M E – L M – L B (95% CI) p
Physical functioning 20.05 (20.42) 23.93 (22.05) 30.77 (24.40) 0.03 <.001 0.18 0.48 0.29 0.09 (0.07–0.11) <.001
Social functioning 57.01 (27.02) 60.64 (24.37) 61.90 (24.37) – .005 – – – 0.03 (0.01–0.05) .003
Role limitations physical 56.78 (39.36) 64.78 (38.48) 71.70 (36.83) 0.02 <.001 0.21 0.39 0.18 0.04 (0.03–0.05) <.001
Role limitations emotional 70.88 (34.54) 80.16 (30.43) 78.40 (32.07) 0.01 <.001 0.29 0.23 – 0.02 (0.01–0.04) .007
Mental health 62.45 (15.17) 62.69 (15.07) 63.88 (16.19) – .21 – – – 0.04 (0.00–0.07) .04
Vitality 64.54 (15.45) 67.26 (15.93) 68.65 (16.43) 0.01 <.001 0.17 0.27 – 0.07 (0.03–0.10) <.001
Bodily pain 32.77 (24.38) 36.71 (27.15) 39.95 (28.22) 0.01 <.001 0.27 – – 0.04 (0.02–0.06) <.001
General health perception 49.86 (20.24) 50.91 (19.51) 52.24 (20.56) – .13 – – – 0.02 (0.01–0.05) .11
Generic health status as measured with the Short Form-36 (SF-36) per age-group in 1950 outpatients diagnosed with DSM-IV-TR anxiety disorders (panic disorder
with or without agoraphobia, agoraphobia without panic, social phobia and/or generalised anxiety disorder). Comparisons between the three age-groups were made
using ANOVA with post-hoc comparisons using Bonferroni correction for multiple testing. Generic health status was measured using the Short Form-36 (SF-36); SF-
36 scores were inverted. DSM-IV-TR denotes Diagnostic Statistical Manual-fourth edition, text revision; E denotes the early adult group (18–25; n¼ 435); M denotes
the mid-adult group (26–40; n¼ 788); L denotes the late adult group (41–65; n¼ 727).
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increased prevalence in our older adult group could be regarded
as an artefact. Alternatively however, the older adult group may
in fact have been more depressed and adequately diagnosed as
such. Possibly, the absence of elevated self-report depression
scores stems from a misattribution of psychiatric symptoms to
general symptoms of ageing by depressed older adults (Knauper
& Wittchen 1994). Overall, the increased prevalence of agorapho-
bia and mood comorbidity in older adults warrants special atten-
tion, as both have been associated with negative outcome (Angst
& Vollrath 1991; Schat et al. 2013).
Both younger groups reported more interpersonal sensitivity
and hostility. These may have emerged from the demands that are
typically made of the younger age-groups, which may have a stron-
ger social component, for example, in achieving independence, pos-
sible student life, dating and career development. In addition,
increased interpersonal sensitivity fits our findings of higher preva-
lence of SP in the younger age-groups, although feelings of hostility
do not. Interestingly, young adult patients’ hostility scores, which
were measured through a subscale on the self-report BSI, as well as
an item on the observer-rated BAS, were elevated only on the self-
report measure, perhaps the single item of the BAS lacked sensitivity
to detect the variation in hostility.
Our study has several strengths. To our knowledge, it is the first
study to report on age-related characteristics of anxiety disorders
across the ages 18 through 65. Furthermore, as we examined outpa-
tients using data from a large, representative naturalistic sample, we
ensured applicability to clinical practice. The inclusion of a broad set
of patient characteristics further strengthens our study. However,
several potential limitations exist. As our study was explorative in
nature, we used unsubstantiated cut-offs to define the age-groups.
Although our cut-offs have been used previously (Regier et al. 1990;
Robins et al. 1984; Somers et al. 2006; van Noorden et al. 2011),
alternative cut-offs may better fit the research question. Second, no
information on primary diagnosis or physical comorbidity was avail-
able in our sample. In addition, it must be noted that although dif-
ferences between groups were significant after correction for
multiple testing, effect sizes indicated that differences were gener-
ally small. This does not imply they are not clinically important, but
it does warrant moderation when interpreting results. Finally, we
studied an outpatient group, therefore, our results may not general-
ise to inpatients or the general population.
In conclusion, our study has convincingly demonstrated that sig-
nificant age related differences exist among outpatients with anxiety
disorders. Although a number of these differences fit expectations
related to development across the adult lifespan, these may still be
of clinical relevance, as they relate to needs felt by patients and
demands made of them. The finding of increased observed but not
self-reported depression in the older adult group merits special
attention in clinical practice as well as in future research. Similarly,
elevated feelings of hostility and interpersonal sensitivity among
younger adults, possibly reflecting strong social demands that are
made of them, should be taken into account. Clinicians should be
aware of these differences when providing treatment.
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